International Journal of Pharmaceutical Compounding

Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2022 - Volume 26, Number 5

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2022 Pg. 430	Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 2021 Pg. 146-155	In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Jan/Feb 2017 Pg. 63	Nifedipine 0.5% Rectal Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 406	Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 238	Nifedipine, Lidocaine, and Nitroglycerin Suppositories Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
Nov/Dec 2010 Pg. 520	Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 344-351	Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Nov/Dec 2010 Pg. 514	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
Mar/Apr 2024 Pg. 111-116	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2020 Pg. 57	Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 540	Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 310-314	Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Author(s): Christiansen Joel, White Lyndell
Jan/Feb 2014 Pg. 14-19	Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Author(s): Zur Eyal

Abstract

Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment

Page(s): 430

Abstract

Related Keywords

Related Categories

Related Articles from IJPC